or Try an Advanced Search...

    Technical Analysis for 0A4Y - AIM ImmunoTech Inc.

    Grade Last Price % Change Price Change
    D 0.42 -4.52% -0.02
    0A4Y closed down 4.52 percent on Tuesday, April 23, 2024, on 1 percent of normal volume.
    Earnings due: May 13
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A N/A Down
    Historical 0A4Y trend table...
    Date Alert Name Type % Chg
    Hot IPO Pullback Bullish Swing Setup 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Gapped Down Weakness 0.00%
    Fell Below 20 DMA Bearish -4.52%
    Hot IPO Pullback Bullish Swing Setup -4.52%
    Narrow Range Bar Range Contraction -4.52%
    Wide Bands Range Expansion -4.52%
    Older End-of-Day Signals for 0A4Y ...

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    TradingView chart

    Profile

    AIM ImmunoTech Inc. Description

    AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat genital warts, a sexually transmitted disease. It has agreements with UMN Pharma Inc.; Japanese National Institute of Infectious Diseases; Shionogi & Co., Ltd.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

    Classification
    Keywords: Disease Hiv Cancers Pancreatic Cancer Chronic Fatigue Syndrome Hepatitis B

    Is 0A4Y a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.599
    52 Week Low 0.375
    Average Volume 5,873
    200-Day Moving Average 0.00
    50-Day Moving Average 0.00
    20-Day Moving Average 0.46
    10-Day Moving Average 0.50
    Average True Range 0.04
    RSI (14) 43.82
    ADX 12.09
    +DI 34.32
    -DI 43.99
    Chandelier Exit (Long, 3 ATRs) 0.49
    Chandelier Exit (Short, 3 ATRs) 0.49
    Upper Bollinger Bands 0.58
    Lower Bollinger Band 0.35
    Percent B (%b) 0.32
    BandWidth 49.48
    MACD Line 0.03
    MACD Signal Line 0.03
    MACD Histogram -0.0037
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.42
    Resistance 3 (R3) 0.42 0.42 0.42
    Resistance 2 (R2) 0.42 0.42 0.42 0.42
    Resistance 1 (R1) 0.42 0.42 0.42 0.42 0.42
    Pivot Point 0.42 0.42 0.42 0.42 0.42
    Support 1 (S1) 0.42 0.42 0.42 0.42 0.42
    Support 2 (S2) 0.42 0.42 0.42 0.42
    Support 3 (S3) 0.42 0.42 0.42
    Support 4 (S4) 0.42